LAQLuis Adrián QuirozSlidesetHIVMexican HIV Clinical Forum 2022Client Experience With Therapeutic HIV Prevention Options - Luis Adrián QuirozView Slideset
ALIAlvaro López IñiguezMDSlidesetHIVMexican HIV Clinical Forum 2022Mexican Treatment Guidelines - Similarities and Differences - Alvaro López IñiguezView Slideset
JLBJosé Luis BlancoMD, PhDSlidesetHIVMexican HIV Clinical Forum 2022Resistance Considerations in Choice of Regimen - José Luis Blanco ArévaloView Slideset
ATAlice TsengB.Sc.Phm., PharmD, FCSHP, AAHIVPSlidesetHIVMexican HIV Clinical Forum 2022Pharmacological Considerations in Choice of Regimen - Alice TsengView Slideset
LESLuis E. Soto-RamírezMDSlidesetHIVMexican HIV Clinical Forum 2022Considerations in Switching to Newer Regimens in Patients Suppressed on Older Drugs - Luis E. Soto-RamírezView Slideset
SlidesetHIVMexican HIV Clinical Forum 2022Second-Line Therapy After NNRTI INSTI Treatments - Ricardo DiazView Slideset
HRHéctor RiveraSlidesetHIVMexican HIV Clinical Forum 2022Clinical Case Presentation - Héctor RiveraView Slideset
DMDulce Morales-PérezSlidesetHIVMexican HIV Clinical Forum 2022Clinical Case Presentation - Dulce Morales-PérezView Slideset
AMAlexandra Martín-OnraëtMD, MScSlidesetHIVMexican HIV Clinical Forum 2022ARV's for Women of Reproductive Age - Alexandra Martín-OnraëtView Slideset
RPRemco PetersMD, PhDSlidesetHIVAfrican HIV Clinical Forum 2022Remco Peters, MD, PhD - Rapid Start – Is It Feasible?View Slideset
VMVictor MusiimeMBChB, MMed, PhDSlidesetHIVAfrican HIV Clinical Forum 2022Victor Musiime, MBChB, MMed, PhD - Dual Regimen – Considerations For Key Populations: AdolescenceView Slideset
FSFrancis SsaliMBChBSlidesetHIVAfrican HIV Clinical Forum 2022Francis Ssali, MBChB - Rapid Start – In Practice: Clinical CaseView Slideset
